Search

Take a look back at some of the year’s biggest news in cancer research.

… Thursday, December 27, 2018 December wouldn’t be complete without a recap of the year’s most important scientific advances in cancer. Memorial Sloan Kettering scientists published hundreds of studies this past year and weighed in as experts on many others. Below are some of the year’s highlights.   1

New research from MSK develops a method for analyzing cancer cells that survive treatment for acute myeloid leukemia; identifies a transcription factor that orchestrates natural killer cell response; and finds vepafestinib is a promising therapeutic for the treatment of RET-driven cancers.

… Friday, September 29, 2023 New research from Memorial Sloan Kettering Cancer Center (MSK) develops a method for analyzing cancer cells that survive treatment for acute myeloid leukemia; identifies a transcription factor that orchestrates natural killer cell response; and finds vepafestinib is a promising

New research from MSK explores novel predictors of immunotherapy effectiveness against lung cancer; identifies how a high-fat diet hinders intestinal damage repair; reports findings from a clinical trial for people with androgen receptor-positive salivary gland cancer; and aims to understand the impact of tumor mutational burden on patients with locally advanced non-small cell lung cancer.

… Friday, January 20, 2023 New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute — MSK’s experimental research arm — explores novel predictors of immunotherapy effectiveness against lung cancer; identifies how a high-fat diet hinders intestinal damage repair;

Why do some patients respond to immunotherapy while others do not? Blood may hold the answer.

… Monday, April 10, 2017 Summary Some patients who receive immunotherapy drugs called checkpoint inhibitors experience significant benefit in terms of tumor shrinkage and longer survival — but many do not. A new study suggests that measuring changes in the blood could help doctors determine whether a person

Researchers from MSK and Weill Cornell have found that two compounds appear to fight off infection with the Zika virus.

… Thursday, July 20, 2017 Summary Researchers from MSK and Weill Cornell have found that two compounds appear to fight off infection with the Zika virus. They made use of several lab technologies to test the drugs. Over the past few years, thousands of babies whose mothers were infected with the mosquito-borne

… Saturday, September 19, 2009 Nineteen undergraduate students joined our community of scientists for ten weeks, working with faculty mentors who helped them to define and realize their research projects. The school welcomed our new class of PhD students, who have completed their first laboratory rotation

Official rare cancer fundraising program of Memorial Sloan Kettering Cancer Center to host its stationary-cycling events in 16 locations nationwide. Instructors from Equinox, Cycle for Survival’s founding partner, will lead the high-energy rides.

… Wednesday, December 17, 2025 Cycle for Survival, the official rare cancer fundraiser of Memorial Sloan Kettering Cancer Center (MSK), has opened registration for the 2026 season of stationary-cycling events, and bikes are already more than 75% full. This special 20th anniversary year features 16 locations

MSK Kids staff made some clever tweaks and a few adjustments to host the ultimate “mask-erade” prom.

… Wednesday, July 22, 2020 This year has been unprecedented in many ways, but it hasn’t stopped our MSK Kids and MSK Staff from celebrating and dancing! Each year, MSK Kids hosts MSK Kids Prom – an event where patients and staff wear fancy dresses, suits and their best face paint and dance the day away

Read about Sandy Freiberg, who ran a marathon to honor his brother, Evan, who is in his fifth year of cancer treatment at Memorial Sloan Kettering.

… Wednesday, January 1, 2020 On September 13, Sandy Freiberg ran a marathon to honor his brother, Evan Freiberg, who is in his fifth year of cancer treatment at Memorial Sloan Kettering. Only Sandy didn’t run the race among a pack of people and with great fanfare at the finish line. He ran 26.2 miles entirely

Learn about a new study led by MSK that suggests that children with cancer are no more likely than other kids to be infected with COVID-19 or to have severe symptoms when infected.

… Friday, May 15, 2020 Summary A study led by MSK sheds light on the risk of COVID-19 infection among children with cancer. A new study led by pediatric cancer specialists at Memorial Sloan Kettering suggests that children with cancer are no more likely than other kids to be infected with COVID-19 or to